February 27, 2021 Comments Off on New patent for Pfizer drug IBRANCE Posted in: Patent Added Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from three suppliers. There are five patents protecting…
The post New patent for Pfizer drug IBRANCE appeared first on DrugPate…
February 27, 2021 Comments Off on New patent for Sarepta Theraps drug EXONDYS 51 Posted in: Patent Added Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Sarepta Theraps drug EXONDYS 51 appeared first on DrugP…
